Cullen Michael T. 4
4 · Sun BioPharma, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Cullen Michael T.
Director
Transactions
- Conversion
Common Stock
2019-06-30+10,495→ 167,995 total - Conversion
Convertible Promissory Note
2019-06-30−35,000→ 0 totalExercise: $3.50From: 2018-12-31Exp: 2019-06-30→ Common Stock (10,495 underlying)
Holdings
- 194,576(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]All amounts due under the note automatically converted into shares of common stock of the Issuer based on conversion price of $3.50 per share upon maturity.